30 hasil untuk "Norrish, Gabrielle"
Menampilkan 1–20 · 0,34 detik · RSS
-
Artikel Jurnal Teks lengkap
Infantile Hypertrophic cardiomyopathy: steps towards an evidence-based approach to genetic testing
-
Artikel Jurnal Teks lengkap
Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
Hypertrophic cardiomyopathy is the second most common cause of cardiomyopathy presenting during childhood and whilst its underlying aetiology is variable, the majority of disease is caused by sarcomeric protein gene variants. Sarcomeric disease can present at any age with highly variable disease…
-
Artikel Jurnal Teks lengkap
Contemporary practice and resource availability for genetic testing in paediatric hypertrophic cardiomyopathy
-
Artikel Jurnal Teks lengkap
Childhood-onset hypertrophic cardiomyopathy caused by thin-filament sarcomeric variants
Up to 20% of children with sarcomeric hypertrophic cardiomyopathy (HCM) have disease-causing variants in genes coding for thin-filament proteins. However, data on genotype-phenotype correlations for thin-filament disease are limited. This study describes the natural history and outcomes of children…
-
Artikel Jurnal Teks lengkap
Imaging based risk factors for heart failure death in childhood dilated cardiomyopathy: a systematic review and meta-analysis
BACKGROUND AND AIM: Dilated cardiomyopathy (DCM) is the most common heart muscle disease presenting in childhood and is associated with an increased risk of heart failure related death. In adult cohorts, imaging characteristics such as increased left ventricular dimensions or the presence of…
-
Artikel Jurnal Teks lengkap
Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy
BACKGROUND: Children with hypertrophic cardiomyopathy (HCM) have historically been considered to be high-risk candidates for general anaesthesia (GA), but there is currently a paucity of evidence regarding the safety of anaesthesia and perioperative outcomes in this population. METHODS: Clinical…
-
Artikel Jurnal Teks lengkap
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
AIMS: The validated HCM Risk-Kids model provides accurate individualized estimates of sudden cardiac death risk in children with hypertrophic cardiomyopathy (HCM). A second validated model, PRIMaCY, also provides individualized estimates of risk, but its performance and clinical impact has not been…
-
Artikel Jurnal Teks lengkap
Racial Variation in Echocardiographic Reference Ranges for Left Chamber Dimensions in Children and Adolescents: A Systematic Review
Echocardiography plays a critical role in the assessment of cardiac disease. Important differences in echocardiographically derived cardiac chamber dimensions have been previously highlighted in different population groups in adult studies, but this has not been systematically studied in children…
-
Artikel Jurnal Teks lengkap
Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
BACKGROUND: Predictive genetic screening of relatives of patients with hypertrophic cardiomyopathy (HCM) caused by sarcomere protein (SP) gene mutations is current standard of care, but there are few data on long-term outcomes in mutation carriers without HCM. OBJECTIVES: The aim of this study was…
-
Artikel Jurnal Teks lengkap
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a heritable myocardial disease with age-related penetrance. Current guidelines recommend clinical screening of relatives beginning at 10 years of age, but the clinical value of this approach has not been systematically evaluated. METHODS: Anonymized…
-
Artikel Jurnal Teks lengkap
Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes
BACKGROUND: Variants in the cardiac myosin-binding protein C gene (MYBPC3) are a common cause of hypertrophic cardiomyopathy (HCM) in adults and have been associated with late-onset disease, but there are limited data on their role in paediatric-onset HCM. The objective of this study was to…
-
Artikel Jurnal Teks lengkap
Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is defined clinically by pathological left ventricular hypertrophy. We have previously developed a plasma proteomics biomarker panel that correlates with clinical markers of disease severity and sudden cardiac death risk in adult patients with HCM. The…
-
Artikel Jurnal Teks lengkap
Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort
Myotonic dystrophy type 1 (DM1) is the most prevalent inherited neuromuscular dystrophy in adults. It is a multisystem disease with cardiac manifestations. Whilst these are well-defined in adults, there are scarce published data in the pediatric population. This study aimed to investigate the yield…
-
Artikel Jurnal Teks lengkap
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines
BACKGROUND: We aimed to examine clinical features, and outcomes of consecutive molecularly characterized patients with NSML and HCM. METHODS: A retrospective, longitudinal multicenter cohort of consecutive children and adults with a genetic diagnosis of NSML and HCM between 2002 and 2019 was…
-
Artikel Jurnal Teks lengkap
Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom
AIMS: Understanding the spectrum of disease, symptom burden and natural history are essential for the management of children with hypertrophic cardiomyopathy (HCM). The effect of changing screening practices over time has not previously been studied. This study describes the clinical…
-
Artikel Jurnal Teks lengkap
Friedreich’s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study
OBJECTIVE: Hypertrophic cardiomyopathy (HCM) is an important predictor of long-term outcomes in Friedreich’s ataxia (FA), but the clinical spectrum and survival in childhood is poorly described. This study aimed to describe the clinical characteristics of children with FA-HCM. DESIGN AND SETTING…
-
Artikel Jurnal Teks lengkap
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
BACKGROUND AND AIMS: Childhood-onset cardiomyopathies are rare and poorly characterized. This study examined the baseline characteristics and 1-year follow-up of children with cardiomyopathy in the first European Cardiomyopathy Registry. METHODS: Prospective data were collected on individuals aged…
-
Artikel Jurnal Teks lengkap
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
AIMS: Sudden cardiac death (SCD) is the most common cause of death in children with hypertrophic cardiomyopathy (HCM). The European Society of Cardiology (ESC) recommends consideration of an implantable cardioverter-defibrillator (ICD) if two or more clinical risk factors (RFs) are present, but…
-
Artikel Jurnal Teks lengkap
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study
AIMS: Sudden cardiac death (SCD) is the most common mode of death in paediatric hypertrophic cardiomyopathy (HCM). This study describes the implant and programming strategies with clinical outcomes following implantable cardioverter-defibrillator (ICD) insertion in a well-characterized national…